Macular Edema and Macular Degeneration Global and China Top Players Market

Macular Edema and Macular Degeneration - Global and China Top Players Market Share and Ranking 2025

Macular Edema and Macular Degeneration Global and China Top Players Market

Macular Edema and Macular Degeneration - Global and China Top Players Market Share and Ranking 2025


The Global Busbar Macular Edema and Macular Degeneration Market investigation report contains Types, Application & all logical and factual briefs about market 2024 Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Allergan, Regeneron Pharmaceuticals Inc, Alimera Sciences, Bausch Health Companies Inc., Kubota Pharmaceutical Holdings Co., Bayer AG

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Macular Edema and Macular Degeneration Market Size and Forecast 2024 to 2031

• The global Macular Edema and Macular Degeneration market was valued at US$ 9861 Million in 2024
• It is estimated to expand at a CAGR of 6.90% % from 2024 to 2031
• The global Macular Edema and Macular Degeneration market is expected to reach the value of US$ 15370 Million by the end of 2031

Macular Edema and Macular Degeneration Market Overview
Macular Edema and Macular Degeneration are two distinct eye conditions that affect the macula, a small but crucial part of the retina responsible for central vision and fine detail.

The market for macular edema treatment has been witnessing advancements in therapeutic options. Anti-VEGF (vascular endothelial growth factor) injections and corticosteroid implants are commonly used to manage macular edema, and new formulations and delivery methods were being explored to enhance treatment effectiveness and patient convenience.

This report studies and analyses global Macular Edema and Macular Degeneration status and future trends, helping the client to determine the Macular Edema and Macular Degeneration market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Macular Edema and Macular Degeneration. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.

Macular Edema and Macular Degeneration Market Key Takeaways

(1) Global Macular Edema and Macular Degeneration market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Macular Edema and Macular Degeneration sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Macular Edema and Macular Degeneration sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Macular Edema and Macular Degeneration key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Macular Edema and Macular Degeneration key producing regions, capacity, production, and year-over-year growth
(6) Macular Edema and Macular Degeneration industry chains, upstream, midstream, and downstream

Macular Edema and Macular Degeneration Market: Key Players

The competitive landscape of the Macular Edema and Macular Degeneration Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Macular Edema and Macular Degeneration Market. Some of the major players operating in the Macular Edema and Macular Degeneration Market are:
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • GlaxoSmithKline plc
  • Allergan
  • Regeneron Pharmaceuticals Inc
  • Alimera Sciences
  • Bausch Health Companies Inc.
  • Kubota Pharmaceutical Holdings Co.
  • Bayer AG


Market IntelliX's study on the Macular Edema and Macular Degeneration market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Macular Edema and Macular Degeneration Market by Type [Analysis by Value from 2020 to 2031]:
  • Macular Edema
  • Macular Degeneration


Macular Edema and Macular Degeneration Market by Application [Analysis by Value from 2020 to 2031]:
  • Hospital
  • Clinic
  • Others


Macular Edema and Macular Degeneration Market by Region [Analysis by Value from 2020 to 2031]:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


Macular Edema and Macular Degeneration Market Report Includes:

Chapter 1: To describe Macular Edema and Macular Degeneration product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Macular Edema and Macular Degeneration market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 3: China Macular Edema and Macular Degeneration market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 4: Global key producing regions of Macular Edema and Macular Degeneration , percent & CAGR, 2020 - 2031

Chapter 5: Macular Edema and Macular Degeneration industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Macular Edema and Macular Degeneration Definition

1.2 Global Macular Edema and Macular Degeneration Market Size and Forecast

1.3 China Macular Edema and Macular Degeneration Market Size and Forecast

1.4 Share of China Macular Edema and Macular Degeneration Market with Respect to the Global Market

1.5 Macular Edema and Macular Degeneration Market Size: China VS Global Growth Rate, 2020-2031

1.6 Macular Edema and Macular Degeneration Market Dynamics

1.6.1 Macular Edema and Macular Degeneration Market Drivers

1.6.2 Macular Edema and Macular Degeneration Market Restraints

1.6.3 Macular Edema and Macular Degeneration Industry Trends

1.6.4 Macular Edema and Macular Degeneration Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Macular Edema and Macular Degeneration, Global Market Share by Company, 2020-2025

2.2 Global Macular Edema and Macular Degeneration Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Macular Edema and Macular Degeneration Concentration Ratio

2.4 Global Macular Edema and Macular Degeneration Mergers & Acquisitions, Expansion Plans

2.5 Global Macular Edema and Macular Degeneration Major Companies Product Type

2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Macular Edema and Macular Degeneration, China Market Share by Company, 2020-2025

3.2 China Macular Edema and Macular Degeneration Macular Edema and Macular Degeneration Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Macular Edema and Macular Degeneration Industry Chain

4.2 Macular Edema and Macular Degeneration Upstream Analysis

4.2.1 Macular Edema and Macular Degeneration Core Raw Materials

4.2.2 Main Manufacturers of Macular Edema and Macular Degeneration Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Macular Edema and Macular Degeneration Production Mode

4.6 Macular Edema and Macular Degeneration Procurement Model

4.7 Macular Edema and Macular Degeneration Industry Sales Model and Sales Channels

4.7.1 Macular Edema and Macular Degeneration Sales Model

4.7.2 Macular Edema and Macular Degeneration Typical Distributors

5 Sights by Type

5.1 Macular Edema and Macular Degeneration Classification

5.1.1 Macular Edema

5.1.2 Macular Degeneration

5.2 by Type, Global Macular Edema and Macular Degeneration Consumption Value & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Macular Edema and Macular Degeneration Consumption Value, 2020-2031

6 Sights by Application

6.1 Macular Edema and Macular Degeneration Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Others

6.2 by Application, Global Macular Edema and Macular Degeneration Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Macular Edema and Macular Degeneration Consumption Value, 2020-2031

7 Sales Sights by Region

7.1 By Region, Global Macular Edema and Macular Degeneration Consumption Value, 2020 VS 2024 VS 2031

7.2 By Region, Global Macular Edema and Macular Degeneration Consumption Value, 2020-2031

7.3 North America

7.3.1 North America Macular Edema and Macular Degeneration Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Macular Edema and Macular Degeneration Market Size Market Share

7.4 Europe

7.4.1 Europe Macular Edema and Macular Degeneration Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Macular Edema and Macular Degeneration Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Macular Edema and Macular Degeneration Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Macular Edema and Macular Degeneration Market Size Market Share

7.6 South America

7.6.1 South AmericaMacular Edema and Macular Degeneration Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Macular Edema and Macular Degeneration Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Macular Edema and Macular Degeneration Market Size & CAGR, 2020 VS 2024 VS 2031

8.2 By Country, Global Macular Edema and Macular Degeneration Consumption Value, 2020-2031

8.3 United States

8.3.1 United States Macular Edema and Macular Degeneration Market Size, 2020-2031

8.3.2 by Type, United States Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.3.3 by Application, United States Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Macular Edema and Macular Degeneration Market Size, 2020-2031

8.4.2 by Type, Europe Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.4.3 by Application, Europe Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.5 China

8.5.1 China Macular Edema and Macular Degeneration Market Size, 2020-2031

8.5.2 by Type, China Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.5.3 by Application, China Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Macular Edema and Macular Degeneration Market Size, 2020-2031

8.6.2 by Type, Japan Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.6.3 by Application, Japan Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Macular Edema and Macular Degeneration Market Size, 2020-2031

8.7.2 by Type, South Korea Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.7.3 by Application, South Korea Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Macular Edema and Macular Degeneration Market Size, 2020-2031

8.8.2 by Type, Southeast Asia Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.8.3 by Application, Southeast Asia Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.9 India

8.9.1 India Macular Edema and Macular Degeneration Market Size, 2020-2031

8.9.2 by Type, India Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.9.3 by Application, India Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Macular Edema and Macular Degeneration Market Size, 2020-2031

8.10.2 by Type, Middle East & Africa Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

8.10.3 by Application, Middle East & Africa Macular Edema and Macular Degeneration Consumption Value Market Share, 2024 VS 2031

9 Company Profile

9.1 F. Hoffmann-La Roche Ltd

9.1.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

9.1.2 F. Hoffmann-La Roche Ltd Company Profile and Main Business

9.1.3 F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Models, Specifications, and Application

9.1.4 F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.1.5 F. Hoffmann-La Roche Ltd Recent Developments

9.2 Novartis AG

9.2.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position

9.2.2 Novartis AG Company Profile and Main Business

9.2.3 Novartis AG Macular Edema and Macular Degeneration Models, Specifications, and Application

9.2.4 Novartis AG Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.2.5 Novartis AG Recent Developments

9.3 GlaxoSmithKline plc

9.3.1 GlaxoSmithKline plc Company Information, Head Office, Market Area, and Industry Position

9.3.2 GlaxoSmithKline plc Company Profile and Main Business

9.3.3 GlaxoSmithKline plc Macular Edema and Macular Degeneration Models, Specifications, and Application

9.3.4 GlaxoSmithKline plc Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.3.5 GlaxoSmithKline plc Recent Developments

9.4 Allergan

9.4.1 Allergan Company Information, Head Office, Market Area, and Industry Position

9.4.2 Allergan Company Profile and Main Business

9.4.3 Allergan Macular Edema and Macular Degeneration Models, Specifications, and Application

9.4.4 Allergan Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.4.5 Allergan Recent Developments

9.5 Regeneron Pharmaceuticals Inc

9.5.1 Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position

9.5.2 Regeneron Pharmaceuticals Inc Company Profile and Main Business

9.5.3 Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Models, Specifications, and Application

9.5.4 Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.5.5 Regeneron Pharmaceuticals Inc Recent Developments

9.6 Alimera Sciences

9.6.1 Alimera Sciences Company Information, Head Office, Market Area, and Industry Position

9.6.2 Alimera Sciences Company Profile and Main Business

9.6.3 Alimera Sciences Macular Edema and Macular Degeneration Models, Specifications, and Application

9.6.4 Alimera Sciences Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.6.5 Alimera Sciences Recent Developments

9.7 Bausch Health Companies Inc.

9.7.1 Bausch Health Companies Inc. Company Information, Head Office, Market Area, and Industry Position

9.7.2 Bausch Health Companies Inc. Company Profile and Main Business

9.7.3 Bausch Health Companies Inc. Macular Edema and Macular Degeneration Models, Specifications, and Application

9.7.4 Bausch Health Companies Inc. Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.7.5 Bausch Health Companies Inc. Recent Developments

9.8 Kubota Pharmaceutical Holdings Co.

9.8.1 Kubota Pharmaceutical Holdings Co. Company Information, Head Office, Market Area, and Industry Position

9.8.2 Kubota Pharmaceutical Holdings Co. Company Profile and Main Business

9.8.3 Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Models, Specifications, and Application

9.8.4 Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.8.5 Kubota Pharmaceutical Holdings Co. Recent Developments

9.9 Bayer AG

9.9.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position

9.9.2 Bayer AG Company Profile and Main Business

9.9.3 Bayer AG Macular Edema and Macular Degeneration Models, Specifications, and Application

9.9.4 Bayer AG Macular Edema and Macular Degeneration Revenue and Gross Margin, 2020-2025

9.9.5 Bayer AG Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Macular Edema and Macular Degeneration Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Macular Edema and Macular Degeneration Market trending toward high growth trajectories?
A dynamic process in the Macular Edema and Macular Degeneration Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Allergan, Regeneron Pharmaceuticals Inc, Alimera Sciences, Bausch Health Companies Inc., Kubota Pharmaceutical Holdings Co., Bayer AG.
How competitive is the Macular Edema and Macular Degeneration Market going to be?
The strategic moves of the Macular Edema and Macular Degeneration Market players such as F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Allergan, Regeneron Pharmaceuticals Inc, Alimera Sciences, Bausch Health Companies Inc., Kubota Pharmaceutical Holdings Co., Bayer AG, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What are the major applications of the Macular Edema and Macular Degeneration Market?
Depending upon the type of applications, the Macular Edema and Macular Degeneration Market has been segmented into and other applications.
How big is the Macular Edema and Macular Degeneration Market by 2030?
It is expected that the Macular Edema and Macular Degeneration Market will reach USD XX million by 2030.
What are the advantages of the Macular Edema and Macular Degeneration Market research study?
The Macular Edema and Macular Degeneration Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
How is the Macular Edema and Macular Degeneration Market's changing dynamics captured?
The Macular Edema and Macular Degeneration analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.